Navigation Links
Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
Date:5/23/2013

gía de la compañía, y el impacto de los datos clínicos y otros datos técnicos. Las declaraciones prospectivas se basan en las actuales expectativas de la dirección y están sujetas a riesgos e incertidumbres que pueden causar que los resultados de Volcano difieran material y adversamente de las declaraciones contenidas aquí. Algunos de los posibles riesgos e incertidumbres que podrían causar que los resultados reales difieran incluyen el ritmo y extensión de la adopción de mercado de los productos y tecnologías de la compañía, resultados clínicos no esperados, incluyendo datos clínicos nuevos no esperados y análisis adicionales de datos clínicos existentes, acciones regulatorias no esperadas o retrasos o regulaciones gubernamentales, la capacidad de la compañía para mantener u obtener patentes o protección de la propiedad intelectual, competencia en general, presiones de la industria en general o de precios públicos, temas no previstos de fabricación, estrategias de crecimiento, la oportunidad y logro de hitos de desarrollo de productos, el resultado de litigios, el impacto y beneficios del desarrollo de mercado, introducciones de productos, nuevos datos no esperados, problemas de seguridad y técnicos, las condiciones del mercado y otros riesgos inherentes al desarrollo y comercialización de dispositivos médicos. Estos y otros riesgos e incertidumbres se describen totalmente en los archivos de Volcano presentados a la Comisión de Bolsa y Valores, incluyendo nuestro informe trimestral reciente en Formulario 10-Q. No debería depositarse una confianza indebida en las declaraciones prospectivas que se refieren solo a la fecha en que se realizaron. Volcano no asume obligación alguna de actualizar las declaraciones prospectivas para reflejar nueva información, eventos o circunstancias después de la fecha en que se r
'/>"/>
SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
2. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
3. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
4. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
5. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
6. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
9. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015 The March 3, 2015, order from ... must change their products, labels to clarify the drugs, intended ... and stroke is necessary to protect the public from injury ... partner at Simmons Hanly Conroy . The ... that the products – currently taken by millions of U.S. ...
(Date:3/4/2015)... CITY, Kan. , March 4, 2015   ... a pet therapeutics company focused on the licensing, development ... today announced that it will present at the ... 10-12, 2015, at the Loews Miami Beach Hotel in ... Steven St. Peter , M.D., President and Chief ...
(Date:3/4/2015)... N.J. , March 4, 2015  Bayer ... Drug Administration (FDA) has accepted the company,s Biologics ... Factor VIII compound.  Bayer is seeking FDA approval ... for the treatment of hemophilia A in children ... to continually bringing new therapies to hemophilia A ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3
... , May 10 /PRNewswire-Asia/ -- On April ... cases with Beijing Un-Assegai Technical &,Trade Co. Ltd. (hereinafter referred ... China , as claimant and U.S. Abbott,Laboratories (Abbott U.S.; ... by the,China International Economic and Trade Arbitration Commission (CIETAC), which,has ...
... , Fla., May 10 Dr. Richard ... with newly diagnosed type 1 diabetes for Protege Encore, a ... of two Phase III studies testing the safety and efficacy ... as Protege, has completed enrollment of more than 530 subjects ...
Cached Medicine Technology:Assegai Wins Big Settlement Against ABBOTT's Subsidiary 2Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes 2
(Date:3/5/2015)... Obesity can cause the human body to ... drinks each day can help promote weight loss in ... advocate Sharon Kleyne and sports doctor Robert Weil, during ... of Water® radio show. , Weil is a ... and sports medicine. His weekly radio show, "The ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Hope For The ... Sporting Clay Shoot to be held at Beretta Shooting Grounds ... 2015. All proceeds from the event will benefit Hope For ... of self, restoring the family unit, and restoring hope for ... will honor our nation’s heroes through a day of clay ...
(Date:3/5/2015)... LOUISIANA (PRWEB) March 05, 2015 ... its continued support of the annual American Heart Association’s ... year, Bret Kolman, Lakeview Regional Chief Executive Officer, is ... place on Saturday, March 21, 2015 at Fontainebleau State ... sponsorship, Lakeview Regional has 20 individual teams participating in ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 ... Professor of Psychiatry and Psychology Department of Neuroscience, ... at the upcoming BioConference Live Neuroscience, a two-day ... , The webcast , titled “Dopamine System ... is scheduled for Thursday, March 18, from 9 ...
(Date:3/5/2015)... San Diego, CA (PRWEB) March 05, 2015 ... of the groundbreaking for Cielo Carmel on March 4 ... court will feature speakers: Sherri Lightner, Council president, ... Affirmed Housing; Charmaine Atherton, Senior Vice President, Southern ... Richard Gentry, President & CEO, San Diego Housing Commission. ...
Breaking Medicine News(10 mins):Health News:Obesity is dehydrating and drinking water promotes weight loss say fresh water advocates 2Health News:Obesity is dehydrating and drinking water promotes weight loss say fresh water advocates 3Health News:Hope For The Warriors Announces New York Clay Shoot to Benefit Military Families 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 3Health News:Anthony Grace, MD, PhD, to Deliver Keynote at BioConference Live Neuroscience 2015 2Health News:Anthony Grace, MD, PhD, to Deliver Keynote at BioConference Live Neuroscience 2015 3Health News:SD City Council President Sherri Lightner and Affirmed Housing Break Ground on Affordable Homes in Carmel Valley 2
... CLARA, Calif., Dec. 3 Coherent, Inc.,(Nasdaq: COHR ... received the,decision of the Board of Directors of The ... 2007 to file its past due periodic reports,for the ... quarterly periods,of 2007 with the Securities Exchange Commission ("SEC") ...
... Mass., Dec. 3 Millennium,Pharmaceuticals, Inc. (Nasdaq: ... the annual American Society of Hematology (ASH) meeting ... visiting the Investors section of the,Company,s website, ... The presentation will be delivered by Millennium ...
... first survey to specifically measure hospital pediatric preparedness, a ... researchers found few U.S. emergency rooms are properly equipped ... Charles Schmitz and Roger J. Lewis was reported in ... the American Academy of Pediatrics. The team of LA ...
... care and lack of transportation combine to limit access, CDC ... Almost 20 percent of Americans, or more than 40 million ... a new U.S. government report released Monday. , Access to ... United States, 2007 report from the Centers for Disease ...
... Vegas and Tucson Marathon Runners, PLEASANT GROVE, Utah, ... to prevent inflammation and pain, but at the same ... at,Appalachian State University and Vanderbilt University, published in,Medicine & ... exercise may be unhealthy in the long term. The ...
... Front Needs of Families with Deployed Service Members ... ... will present $15,000 to the Missouri National Guard -,Missouri Military Family Relief Fund, ... their families., Don Brown, market vice president for the central market area ...
Cached Medicine News:Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 2Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 3Health News:Millennium Pharmaceuticals Announces Webcast of American Society of Hematology Investor Event 2Health News:LA BioMed researchers find few emergency rooms fully equipped for pediatric patients 2Health News:Almost 1 in 5 Americans Going Without Health Care 2Health News:Almost 1 in 5 Americans Going Without Health Care 3Health News:Marathoners Share Tom Brady and LaDainian Tomlinson Pain Relief Affinity 2Health News:TriWest Contributes $15,000 to Missouri National Guard Fund 2
... enables highly sensitive time-resolved fluorescence detection ... fluorophores. These compounds are excited with ... fluorescence lifetimes (several hundred microseconds), large ... profiles at 620 nm. Therefore with ...
... most advanced multi-functional microplate detection system, ... performance without compromising flexibility. ,The ... on the Ultra instrument platform. New ... adds to the flexibility of the ...
... OPTIMA is a fully automated microplate ... different measurement principles:, , Fluorescence Polarization ... Fluorescence , High-Performance Luminescence (flash ... ,It is designed for the ...
... FLUOstar is a flexible multifunction plate reader ... one instrument: fluorescence intensity, time-resolved fluorescence, high-perfomance ... be equipped with injectors that deliver reagent ... fast kinetic cell assays can be performed ...
Medicine Products: